Back
OrganiGram Holdings Vs. Acasti Pharma Industry Stock Comparison
Sell
28
OGI
OrganiGram Holdings
Last Price:
1.76
Seasonality Move:
-5.77%
Sell
50
ACST
Acasti Pharma
Last Price:
2.76
Seasonality Move:
19.61%
Sell
28
OrganiGram Holdings (OGI)
is a Sell
Is OrganiGram Holdings a Buy, Sell or Hold?
- The current OrganiGram Holdings [OGI] share price is $1.76. The Score for OGI is 28, which is 44% below its historic median score of 50, and infers higher risk than normal.
- OGI is currently trading in the 20-30% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Sell
50
Acasti Pharma (ACST)
is a Sell
Is Acasti Pharma a Buy, Sell or Hold?
- The current Acasti Pharma [ACST] share price is $2.76. The Score for ACST is 50, which is 0% below its historic median score of 50, and infers higher risk than normal.
- ACST is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
OGI Stock Price Chart
What is OrganiGram Holdings's stock price today?
-
The OrganiGram Holdings share price today is $1.76
Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and OGI is experiencing selling pressure, which indicates risk of future bearish movement.
ACST Stock Price Chart
What is Acasti Pharma's stock price today?
-
The Acasti Pharma share price today is $2.76
Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and ACST is experiencing selling pressure, which indicates risk of future bearish movement.
OGI Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | -0.07 | Sell |
Relative Strength Index (14 RSI): | 40.75 | Sell |
Chaikin Money Flow: | -390694 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (1.8 - 2.02) | Sell |
Bollinger Bands (100): | (1.57 - 2.19) | Sell |
ACST Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | -0.11 | Sell |
Relative Strength Index (14 RSI): | 35.91 | Sell |
Chaikin Money Flow: | -2320 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (2.79 - 3.27) | Sell |
Bollinger Bands (100): | (2.53 - 3.37) | Sell |
OGI Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 1.83 | Sell |
20-day SMA: | 1.87 | Sell |
50-day SMA: | 2.04 | Sell |
200-day SMA: | 1.61 | Buy |
8-day EMA: | 1.82 | Sell |
20-day EMA: | 1.89 | Sell |
50-day EMA: | 1.95 | Sell |
200-day EMA: | 1.9 | Sell |
ACST Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 2.88 | Sell |
20-day SMA: | 2.94 | Sell |
50-day SMA: | 3.22 | Sell |
200-day SMA: | 2.62 | Buy |
8-day EMA: | 2.85 | Sell |
20-day EMA: | 2.95 | Sell |
50-day EMA: | 3.04 | Sell |
200-day EMA: | 2.92 | Sell |
OrganiGram Holdings Earnings Growth & OGI Earnings Dates
- Analysts estimate an earnings increase this quarter of $0.05 per share, a decrease next quarter of $0.00 per share, an increase this year of $1.83 per share, and an increase next year of $0.17 per share.
Acasti Pharma Earnings Growth & ACST Earnings Dates
- Analysts estimate an earnings increase this quarter of $0.08 per share, an increase next quarter of $0.07 per share, an increase this year of $1.16 per share, and an increase next year of $0.34 per share.
OrganiGram Holdings Technical Analysis
Apr 29 | Apr 30 | May 1 | May 2 | May 3 | May 6 | May 7 | May 8 | May 9 | May 10 | |
---|---|---|---|---|---|---|---|---|---|---|
Apr | May | |||||||||
29 | 30 | 01 | 02 | 03 | 06 | 07 | 08 | 09 | 10 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |
Acasti Pharma Technical Analysis
Apr 29 | Apr 30 | May 1 | May 2 | May 3 | May 6 | May 7 | May 8 | May 9 | May 10 | |
---|---|---|---|---|---|---|---|---|---|---|
Apr | May | |||||||||
29 | 30 | 01 | 02 | 03 | 06 | 07 | 08 | 09 | 10 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |